טוען...
Management of atypical chronic lymphocytic leukemia presenting with extreme leukocytosis
Atypical chronic lymphocytic lymphoma (CLL) with CCND1 translocation is poorly described, particularly in the era of modern inhibitors of the B‐cell receptor pathway. We present a patient with atypical CLL who had a significant response to ibrutinib, highlighting the effectiveness of this agent in h...
שמור ב:
| הוצא לאור ב: | Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7250984/ https://ncbi.nlm.nih.gov/pubmed/32477538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2773 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|